Conjugated Polymer Containing Organic Radical for Optical/MR Dual-Modality Bioimaging
Source abstract
Abstract
Optical/MRI bimodal probes have attracted much attention due to palmary soft tissue resolution and high imaging sensitivity. In this study, poly[fluorene- co -alt- p -phenylene] containing organic radical ( PFP-TEMPO+ ) is successfully developed for optical and MRI dual-modality bioimaging. PFP-TEMPO+ displays advanced properties such as fluorescence emission, high photostablilty, reasonable T 1 relaxation effect, low cytotoxicity, and good biocompatibility. Moreover, the ability of PFP-TEMPO+ for tumor tissues imaging confirms that it could be used as an optical and MRI imaging probe for in vivo imaging. The results of the present work disclose the potential applications of PFP-TEMPO+ as an optical and MRI contrast agent.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Luminescence and Fluorescent Materials · Nanoplatforms for cancer theranostics · Conducting polymers and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Medical Imaging Center, Nanfang Hospital, ‡Guangdong Provincial Key Laboratory of Medical Image Processing, School of Biomedical Engineering, and §School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, People’s Republic of China
Funding
Ministry of Science and Technology of the People's Republic of China · National Natural Science Foundation of China · Natural Science Foundation of Guangdong Province · Guangdong Province
References (45)
Show source-provided references
1. 10.1038/nmat239810.1038/nmat2398 ↗
2. 10.1021/cr500698d10.1021/cr500698d ↗
3. 10.1021/cr200358s10.1021/cr200358s ↗
4. 10.1016/j.addr.2013.11.01310.1016/j.addr.2013.11.013 ↗
5. 10.1021/cr900353810.1021/cr9003538 ↗
6. 10.1515/ntrev-2012-008010.1515/ntrev-2012-0080 ↗
7. 10.1016/j.biomaterials.2007.12.03610.1016/j.biomaterials.2007.12.036 ↗
8. 10.1021/cr300213b10.1021/cr300213b ↗
9. 10.1021/acs.biomac.6b0138910.1021/acs.biomac.6b01389 ↗
10. 10.1021/acsami.5b1061710.1021/acsami.5b10617 ↗
11. 10.1039/C6NR00267F10.1039/C6NR00267F ↗
12. 10.1039/C4NR01491J10.1039/C4NR01491J ↗
13. 10.1002/cmmi.48910.1002/cmmi.489 ↗
14. 10.1021/nn800590n10.1021/nn800590n ↗
15. 10.1039/c0jm00007h10.1039/c0jm00007h ↗
16. 10.1038/nmeth.124810.1038/nmeth.1248 ↗
17. 10.1021/ja400337p10.1021/ja400337p ↗
18. 10.1021/acs.chemrev.6b0041910.1021/acs.chemrev.6b00419 ↗
19. 10.1021/ar400254j10.1021/ar400254j ↗
20. 10.1039/b907993a10.1039/b907993a ↗
21. 10.1039/b909065g10.1039/b909065g ↗
22. 10.1021/cr200263w10.1021/cr200263w ↗
23. 10.1021/ja202877q10.1021/ja202877q ↗
24. 10.1039/C5TB02293B10.1039/C5TB02293B ↗
25. 10.1021/acsami.5b1113510.1021/acsami.5b11135 ↗
26. 10.1021/acsami.5b1113510.1021/acsami.5b11135 ↗
27. 10.1021/acsami.6b0549510.1021/acsami.6b05495 ↗
28. 10.1039/C5TB00064E10.1039/C5TB00064E ↗
29. 10.1039/c1cc10991j10.1039/c1cc10991j ↗
30. 10.1002/adma.20110215110.1002/adma.201102151 ↗
31. 10.1002/1521-4095(20020404)14:7<477::AID-ADMA477>3.0.CO;2-910.1002/1521-4095(20020404)14:7<477::AID-ADMA477>3.0.CO;2-9 ↗
32. 10.1002/marc.20060021410.1002/marc.200600214 ↗
33. 10.2174/156802661131304000210.2174/1568026611313040002 ↗
34. 10.2147/IJN.S14451510.2147/IJN.S144515 ↗
35. 10.1002/smll.20150275410.1002/smll.201502754 ↗
36. 10.1039/C4CS00345D10.1039/C4CS00345D ↗
37. 10.1021/acsnano.6b0550210.1021/acsnano.6b05502 ↗
38. 10.1039/B709883A10.1039/B709883A ↗
39. 10.1039/C2CS15261D10.1039/C2CS15261D ↗
40. 10.2214/ajr.141.6.120910.2214/ajr.141.6.1209 ↗
41. 10.1148/radiology.147.3.634203410.1148/radiology.147.3.6342034 ↗
42. 10.1002/mabi.20140040310.1002/mabi.201400403 ↗
43. 10.1039/C4NR07591A10.1039/C4NR07591A ↗
44. 10.1021/acsmacrolett.5b0014510.1021/acsmacrolett.5b00145 ↗
45. 10.1002/adma.20130520610.1002/adma.201305206 ↗